Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRD1 | P41143 | 16/20 | 0.69 |
| ▸ | OPRM1 | P35372 | 10/20 | 0.69 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.69 |
| ▸ | CCKAR | P32238 | 3/20 | 0.57 |
| ▸ | CCKBR | P32239 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30153107 | 0.92 | OPRD1 (0.63) | OPRD1OPRM1OPRK1 | |
| SCHEMBL29626871 | 0.89 | OPRD1 (0.70) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL16620196 | 0.88 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11683986 | 0.88 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11396067 | 0.88 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11124725 | 0.88 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL11396064 | 0.88 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| Dadle SCHEMBL28363457 | 0.88 | OPRD1 (0.80) | OPRD1OPRM1OPRK1 | |
| SCHEMBL9819593 | 0.88 | OPRD1 (0.71) | OPRD1OPRM1OPRK1CCKARCCKBR | |
| SCHEMBL30368328 | 0.87 | LTA4H (0.61) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053954-A1 | Benzaldehyde acetal acid-degradable amphiphilic lipid and self-assembling peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-26 | — | — | US | claimed |
| US-20260053954-A1 | Benzaldehyde acetal acid-degradable amphiphilic lipid and self-assembling peptides | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-02-26 | — | — | US | disclosed |
| US-20250228875-A1 | METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2025-07-17 | — | — | US | disclosed |
| WO-2025076396-A1 | METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2025-04-10 | — | — | WO | disclosed |
| EP-4499131-A2 | METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME | The Trustees of The University of Pennsylvania (US) | 2025-02-05 | — | — | EP | disclosed |
| CN-119365210-A | Methods and kits for treating, ameliorating and/or preventing progressive ossified fibrous tissue dysplasia and ectopic ossification | 宾夕法尼亚大学董事会 | 2025-01-24 | — | — | CN | disclosed |
| WO-2023192880-A2 | METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-10-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260053954-A1 | Benzaldehyde acetal acid-degradable amphiphilic lipid and self-assembling peptides | BAX, BAD, BCL2 | OPRD1 1223/4885OPRM1 2486/4885OPRK1 2949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.